The FDA has approved the first artificial intelligence-powered device that can be used to help identify colorectal lesions during the millions of colonoscopies carried out each year in the US.

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of ...

Discover the revolutionary blood test offering a less invasive alternative to colonoscopies for colorectal cancer detection.

The researchers tried the experimental blood test on more than 40,000 people aged between 45 to 85 at 200 sites across the ...

But remember, colon cancer is a potentially preventable cancer. We want to identify those patients who have high risk lesions like polyps or advanced polyps before they get cancer. Fit and ...

A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S. p ...

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers ...

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

The present study compared interpretation times between NBI and MCE techniques in distinguishing between neoplastic and non-neoplastic small colorectal lesions. Methods: Between January and March ...

The company’s robot will be assessed for both safety and performance in robotic endoscopic submucosal dissection (ESD) procedures for the removal of colorectal lesions. The primary outcome of ...